Prudential Financial
RGLS

Prudential Financial’s Regulus Therapeutics RGLS Stock Holding History

Prudential Financial’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-346
Closed -$703K – 2252
2015
Q1 		$703K Sell
346
-81
-19% -$176K ﹤0.01% 1920
2014
Q4 		$821K Sell
427
-89
-17% -$158K ﹤0.01% 1800
2014
Q3 		$423K Sell
516
-7
-1% -$5.92K ﹤0.01% 1952
2014
Q2 		$505K Sell
523
-67
-11% -$57.4K ﹤0.01% 2008
2014
Q1 		$639K Buy
590
+402
+214% +$446K ﹤0.01% 1886
2013
Q4 		$166K Buy
+188
New +$162K ﹤0.01% 2201

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Prudential Financial's RGLS Position: Q2 2015 in Review

Prudential Financial sold out of Regulus Therapeutics (RGLS) in Q2 2015, closing a stake of 346 shares — an estimated $703K sold.

Prudential Financial first reported a position in RGLS in Q4 2013 and held it in 6 quarters. The position peaked at $821K in Q4 2014. 92 funds tracked by Wall St. Rank hold RGLS as of Q2 2015.

  • Prudential Financial reported no remaining Regulus Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Prudential Financial sold 346 Regulus Therapeutics shares in Q2 2015, an estimated $703K.
  • Prudential Financial first reported a position in Regulus Therapeutics in Q4 2013 and held it in 6 quarters.
  • Prudential Financial's Regulus Therapeutics position peaked at $821K in Q4 2014.
  • 92 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2015.

Based on Prudential Financial's 13F filing for Q2 2015, filed 6 Aug 2015.